Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 302 followers
Latest posts
Last updated about 8 hours ago
'It's just ugly': Federal funding cuts to Columbia University leave chronic fatigue research in limbo
about 8 hours ago
Earlier this month, Ian Lipkin, M.D., and his team at Columbia University...
Visby Medical nets FDA clearance for completely at-home STI test
about 11 hours ago
Visby's kit includes vaginal self-collection swabs and a palm-sized, PCR-based testing device...
Relmada reconsiders phase 2 plans to test magic mushroom extract for obesity
about 13 hours ago
Relmada Therapeutics’ attempts to see whether a magic mushroom extract could be...
What diversity means in medtech
about 14 hours ago
This week on "The Top Line," we hear from Nada Hanafi, co-founder...
Chutes & Ladders—Yet another exec departs CRISPR
about 14 hours ago
CRISPR Therapeutics’ Julianne Bruno is hitting the exit in favor of external...
BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific
about 15 hours ago
BioNTech has shown why it made small cell lung cancer a priority...
Fierce Biotech Layoff Tracker 2025: Nkarta cuts 53 roles; ElevateBio trims team
about 15 hours ago
As always, if you know of layoffs occurring at a biotech, please...
Fierce Biotech Fundraising Tracker '25: Epicrispr claims $68M series B; Character clinches $93M
about 15 hours ago
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million...
Novo inks $1B biobucks Lexicon obesity deal after seeing preclinical prospect shine with semaglutide
about 15 hours ago
Lexicon Pharmaceuticals’ pursuit of the last word in obesity candidates has attracted...
Spero halts development on another antibiotic in latest reprioritization
about 16 hours ago
Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to also...
BioAtla lays off 30% of staff, hunts out partners for ADC and cancer antibody
about 16 hours ago
BioAtla is laying off 30% of staff as the biotech searches for...
ImmuneOnco axes CD47 bispecific as pipeline prioritization pressures hit Chinese biotech
1 day ago
ImmuneOnco Biopharmaceuticals has shown Chinese biotechs are far from immune to the...